Skip to main content


Health

During a phase one clinical trial of a new treatment for MS patients, researchers were able to curtail the body's attacks on myelin by 50 to 75 percent, while sustaining the functionality of the rest of the immune system.
379 of 1587



Newsletter Sign Up

Daily Readings

Reading 1, Ephesians 4:7-16
On each one of us God's favour has been bestowed in whatever ... Read More

Psalm, Psalms 122:1-2, 3-4, 4-5
[Song of Ascents Of David] I rejoiced that they said to me, ... Read More

Gospel, Luke 13:1-9
It was just about this time that some people arrived and told ... Read More

Saint of the Day

October 25 Saint of the Day

St. Daria
October 25: There is very little known about them. Chrysanthus was an ... Read More